mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.6 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |